Article

Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study.

Department of Orthopedics, Assaf Harofeh Medical Center, Zerifin, Israel.
BMC Complementary and Alternative Medicine (Impact Factor: 1.88). 06/2011; 11:50. DOI: 10.1186/1472-6882-11-50
Source: PubMed

ABSTRACT Patients with osteoarthritis (OA) take a variety of health supplements in an attempt to reduce pain and improve function. The aim of this study was to determine the efficacy of methylsulfonylmethane (MSM) in treating patients with knee OA.
This study was a prospective, randomized, double-blind, controlled clinical trial. Forty nine men and women 45-90 (mean 68 ± SD 7.3) years of age with knee OA according to the American College of Rheumatology clinical criteria for OA of the knee and with radiographic confirmed knee OA were enrolled in the study and randomly assigned into 2 groups: One received MSM in doses of 1.125 grams 3 times daily for 12 weeks and the other received a placebo in the same dosing frequency. The primary outcomes were the WOMAC Osteoarthritis Index for pain, stiffness and physical function, the Aggregated Locomotor Function (ALF) test that evaluates each patient's physical function, the SF-36 quality of life health survey and the visual-analogue-scale (VAS) for pain. The secondary outcomes were Knee Society Clinical Rating System for Knee Score (KSKS) and Function Score (KSFS). Patients were assessed at baseline, 6 weeks and 12 weeks. All continuous variables were tested by the Kolmogorov-Smirnov test for Normal distribution. Changes within the groups and differences between the groups were calculated by repeated measures of analysis (ANOVA) with one nested variable.
There were significant differences between treatment groups over time in WOMAC physical function (14.6 mm [CI: 4.3, 25.0]; p = 0.04) and in WOMAC total score (15.0 mm [CI: 5.1, 24.9]; p = 0.03). Treatment groups did not differ significantly in WOMAC pain (12.4 mm [CI: 0.0, 24.8]); p = 0.08) or WOMAC stiffness (27.2 mm [CI: 8.2, 46.2]; p = 0.08). There was a non-significant difference in SF-36 total score between treatment groups (11.6 [CI: 1.0, 22.1]; p = 0.54). A significant difference was found between groups in VAS for pain (0.7 s [CI: -0.9, 2.4]; p = 0.05). Secondary outcomes showed non-significant differences between the two groups.
Patients with OA of the knee taking MSM for 12 weeks showed an improvement in pain and physical function. These improvements, however, are small and it is yet to be determined if they are of clinical significance.
ClinicalTrials.gov: NCT01188213.

Download full-text

Full-text

Available from: Gabriel Agar, Jun 22, 2015
0 Followers
 · 
152 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective. The aim of this study is to systematically evaluate the evidence whether traditional Chinese herbal patches (TCHPs) for osteoarthritis (OA) are effective and safe and analyze their medication patterns. Methods. A systematic literature search was performed using all the possible Medical Subject Headings (MeSH) and keywords from January 1979 to July 2013. Both randomized controlled trials (RCTs) and observational studies were included. Estimated effects were analyzed using mean difference (MD) or relative risk (RR) with 95% confidence intervals (CI) and meta-analysis. Results. 86 kinds of TCHPs were identified. RCTs and controlled clinical trials (CCTs) which were mostly of low quality favored TCHPs for local pain and dysfunction relief. TCHPs, compared with diclofenac ointment, had significant effects on global effectiveness rate (RR = 0.50; 95% CI (0.29, 0.87)). Components of formulae were mainly based on the compounds "Xiao Huo Luo Dan" (Minor collateral-freeing pill) and "Du Huo Ji Sheng Tang" (Angelicae Pubescentis and Loranthi decoction). Ten kinds of adverse events (AEs), mainly consisting of itching and/or local skin rashes, were identified after 3-4 weeks of follow-up. Conclusions. TCHPs have certain evidence in improving global effectiveness rate for OA; however, more rigorous studies are warranted to support their use.
    Evidence-based Complementary and Alternative Medicine 01/2014; 2014:343176. DOI:10.1155/2014/343176 · 2.18 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper reports the first gas chromatography method with flame ionization detection (GC–FID) for rapid assay of the quality control of methylsulfonylmethane (MSM) content in multicomponent dietary supplements. The proposed method was completely validated and used for quality control of multicomponent dietary supplements available in the local market. The study showed that the content of MSM varied in different commercial samples (77.7–112.3 % of the declared amount) and was dependent on different qualities of the dietary supplement producer. The developed method was based on the rapid extraction of MSM into acetone using ultrasound bath (5 min) and on the subsequent quantification of the MSM by gas chromatography. The used GC conditions were as follows: fused silica cyanopropylphenylmethylpolysiloxane capillary column Alltech ATTM-624 (30 m × 0.32 mm i.d., 1.8-μm film thickness), injection mode split of 1:10, sample volume of 1.0 μL, injector temperature of 190 °C, detector temperature of 190 °C, column temperature held at 190 °C for whole analysis time, and helium carrier gas flow rate of 0.7 mL min−1. Nitrobenzene was chosen as internal standard for precise and accurate quantification of MSM in dietary supplements. Method precision evaluated as relative standard deviation was 1.7 %, and method accuracy evaluated as recovery was in the range of 102.5–106.2 %. The method required no special sample pretreatment, so it showed to be simple, robust, rapid (short analysis time of less than 4 min), and suitable for routine analysis of MSM in food quality control laboratories.
    Food Analytical Methods 05/2014; 7(5). DOI:10.1007/s12161-013-9722-5 · 1.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Arthritis affects both the physical and psychological abilities of people in all walks of life. There are currently no recommended effective 'disease-modifying' remedies. Therapists and physicians are therefore exploring possible benefits from non-conventional therapeutic approaches. The purpose is to assess the changes in fitness and psychosocial outcomes of six doctor-referred patients as a result of participating in the I Can Move Again (ICMA) program. Six female participants diagnosed with arthritis were recruited from a local family practitioner. The subjects participated in a series of daily classes for 12 weeks including massage, mindfulness, bounce-back chairs, resistance chairs, aerobic and anaerobic training, rebounders, and whole body vibration platform Tai Chi. Demographic, psychosocial, and physical data were collected at the ICMA and at Y-Be-Fit (Provo, UT). Significant pre to post mean differences were found for sit-ups (F (1,8) =5.42 P =0.048), chair stand (F (1,10) =6.622 P =0.028), arm curl (F (1,10) =14.379 P =0.004), six-minute walk test distance (F (1,9)= 19.188 P=0.002), and speed (F,(1,8) =13.984 P =0.006), and rotation right (F (1,10) =8.921 P =0.014) and left (F (1,10) =11.373 P =0.007), in 27 of the 61-item questionnaire. The preliminary data on the six subjects lacked sufficient statistical power to detect the significant differences that could exist, thus committing a Type II error, but it is important to note an overall, substantial trend in improvement in the patients' physical outcomes and psychosocial perceptions associated with improvements in activities of daily living.
    04/2014; 4(2):99-107. DOI:10.4103/2225-4110.124364